BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10499614)

  • 1. Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma.
    Filipits M; Drach J; Pohl G; Schuster J; Stranzl T; Ackermann J; Königsberg R; Kaufmann H; Gisslinger H; Huber H; Ludwig H; Pirker R
    Clin Cancer Res; 1999 Sep; 5(9):2426-30. PubMed ID: 10499614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of integrin beta1 expression in bone marrow cells after chemotherapy correlates with the overexpression of lung resistance protein and poor outcome in patients with multiple myeloma.
    Kurata M; Nakagawa Y; Yamamoto K; Suzuki K; Kitagawa M
    Am J Hematol; 2008 Sep; 83(9):755-7. PubMed ID: 18615555
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic value of the lung resistance-related protein (LRP) in germ cell testicular tumors.
    Mándoky L; Géczi L; Doleschall Z; Bodrogi I; Csuka O; Kásler M; Bak M
    Anticancer Res; 2004; 24(2C):1097-104. PubMed ID: 15154630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
    Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
    Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy.
    Palumbo A; Bringhen S; Falco P; Cavallo F; Ambrosini MT; Avonto I; Gay F; Caravita T; Bruno B; Boccadoro M
    Cancer; 2007 Aug; 110(4):824-9. PubMed ID: 17594696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the lung resistance protein (LRP) in primary breast cancer.
    Pohl G; Filipits M; Suchomel RW; Stranzl T; Depisch D; Pirker R
    Anticancer Res; 1999; 19(6B):5051-5. PubMed ID: 10697509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy.
    Rudas M; Filipits M; Taucher S; Stranzl T; Steger GG; Jakesz R; Pirker R; Pohl G
    Breast Cancer Res Treat; 2003 Sep; 81(2):149-57. PubMed ID: 14572157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of multidrug resistance proteins as a predictor of poor response to chemotherapy and prognosis in patients with nodal diffuse large B-cell lymphoma.
    Ohsawa M; Ikura Y; Fukushima H; Shirai N; Sugama Y; Suekane T; Hirayama M; Hino M; Ueda M
    Oncology; 2005; 68(4-6):422-31. PubMed ID: 16020972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and clinical significance of beta-catenin in multiple myeloma].
    Li J; Zhang DB; Luo SK; Zhao Y; Huang BH; Gu JL
    Ai Zheng; 2007 Sep; 26(9):1010-4. PubMed ID: 17927863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of glutathione S-transferase and lung resistance-related proteins in acute leukemia and its clinical significance].
    Zhang ZM; Xie ZX; Tan DR; Huang CH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):292-4. PubMed ID: 16045016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung-resistance-related protein expression is a negative predictive factor for response to conventional low but not to intensified dose alkylating chemotherapy in multiple myeloma.
    Raaijmakers HG; Izquierdo MA; Lokhorst HM; de Leeuw C; Belien JA; Bloem AC; Dekker AW; Scheper RJ; Sonneveld P
    Blood; 1998 Feb; 91(3):1029-36. PubMed ID: 9446666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of lung resistant-related protein in ovarian cancer and its clinical significance].
    Qian XL; Peng ZL; Liu SL; Wang H; Ni J
    Ai Zheng; 2002 Dec; 21(12):1332-4. PubMed ID: 12520742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low p27Kip1 expression is an independent adverse prognostic factor in patients with multiple myeloma.
    Filipits M; Pohl G; Stranzl T; Kaufmann H; Ackermann J; Gisslinger H; Greinix H; Chott A; Drach J
    Clin Cancer Res; 2003 Feb; 9(2):820-6. PubMed ID: 12576455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the lung resistance protein in primary colorectal carcinomas.
    Pohl G; Suchomel RW; Stranzl T; Depisch D; Stiglbauer W; Filipits M; Pirker R
    Anticancer Res; 2001; 21(1A):201-4. PubMed ID: 11299735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression.
    Mateos MV; Hernández JM; Hernández MT; Gutiérrez NC; Palomera L; Fuertes M; Garcia-Sanchez P; Lahuerta JJ; de la Rubia J; Terol MJ; Sureda A; Bargay J; Ribas P; Alegre A; de Arriba F; Oriol A; Carrera D; García-Laraña J; García-Sanz R; Bladé J; Prósper F; Mateo G; Esseltine DL; van de Velde H; San Miguel JF
    Haematologica; 2008 Apr; 93(4):560-5. PubMed ID: 18322252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of lung resistance protein and multidrug resistance-associated protein in naive childhood acute leukemia and their clinical significance].
    Zhang JB; Sun Y; Dong J; Liu LX; Ning F
    Ai Zheng; 2005 Aug; 24(8):1015-7. PubMed ID: 16086885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of the lung resistance protein in diffuse large B-cell lymphomas.
    Filipits M; Jaeger U; Simonitsch I; Chizzali-Bonfadin C; Heinzl H; Pirker R
    Clin Cancer Res; 2000 Sep; 6(9):3417-23. PubMed ID: 10999723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of lung resistance-related protein in transitional cell carcinoma of bladder.
    Zhu Y; Kong C; Zeng Y; Sun Z; Gao H
    Urology; 2004 Apr; 63(4):694-8. PubMed ID: 15072883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.